Singapore

SCG Cell Therapy and A*STAR Launch Joint Labs to Advance Cellular Immunotherapy in Singapore

Collaboration aims to develop scalable GMP-grade iPSC manufacturing processes and therapeutic candidates to facilitate research leading to translation of...

 April 18, 2024 | News

Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing

Proprietary Aptegra™ platform reduces five assays to one Results in 66% faster testing time and significantly lower cost for clients compared to t...

 April 17, 2024 | News

Singapore's NUH to Open National University Centre for Digestive Health by 2025

The National University Hospital (NUH) is embarking on a major initiative to establish the National University Centre for Digestive Hea...

 April 17, 2024 | News

Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO

    Mike McMullen, whose tenure at Agilent has been marked by outstanding leadership and unwavering commitment to the company's mission, was ho...

 April 17, 2024 | News

Singapore-Based Respiree Expands to U.S., Establishes Presence at Johnson & Johnson Innovation Hub in South San Francisco

Respiree announced that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @ South San Francis...

 April 16, 2024 | News

Gilead Sciences Invests US$4 Million in Global Fight Against Viral Hepatitis

Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant    World Hepatitis Allianc...

 April 16, 2024 | News

GSK's Trelegy Ellipta Gets Singapore HSA Approval for Asthma, Expands Beyond COPD.

GSK Singapore announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength for Trelegy Ellipta (fluticasone fur...

 April 08, 2024 | News

ZEISS Acquires D.O.R.C., Eyeing Future Innovations in Ophthalmology

 This acquisition, now fully approved by regulatory bodies, not only expands ZEISS's ophthalmic portfolio but also reinforces its standing as a trailb...

 April 05, 2024 | News

From Silicon to Medicine: Steffen Lang Details Novartis' Digital Makeover in Singapore

Steffen Lang, President of Operations at Novartis, shares an insider's perspective with BioPharma APAC on the digital transformation and strategic expansio...

 March 22, 2024 | News

A New Dawn in Heart Care: Singapore Leads with Innovative CVD Prevention Plan

    In an interaction with BioPharma APAC, Dr. Low Lip Ping, Chairman Emeritus of the Singapore Heart Foundation, sheds light on the critical f...

 March 20, 2024 | Interaction

Singapore Approves Everest Medicines' NEFEGAN® for Adult Primary IgA Nephropathy

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commerc...

 March 20, 2024 | News

WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Facility in Singapore

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced ...

 March 19, 2024 | News

BioNTech Amplifies Singapore's Biopharma Innovation with BioPIPS Entry

Singapore's biopharmaceutical landscape has taken a significant leap forward with the expansion of the Biologics Pharma Innovation ...

 March 18, 2024 | News

Novartis Invests $256 Million to Expand Biopharmaceutical Manufacturing in Singapore, Bolstering Asian Market Supply

  Invests US$256 million to expand biopharmaceutical manufacturing facility in Singapore, addressing the soaring demand in the Asian market  ...

 March 15, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close